First generation versus new generation drug‐eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: The Milan and New …

T Naganuma, A Chieffo, K Takagi… - Catheterization and …, 2015 - Wiley Online Library
Objectives To compare the clinical outcomes following unprotected left main coronary artery
(ULMCA) percutaneous coronary intervention (PCI) of ostial/midshaft lesions between first …

[HTML][HTML] Long-term follow-up of percutaneous coronary intervention of unprotected left main lesions with drug eluting stents: predictors of clinical outcome

A Pavei, JA Oreglia, G Martin… - …, 2009 - eurointervention.pcronline.com
Aims: To evaluate the long-term follow-up of drug-eluting stents (DES) in the treatment of
unprotected left main coronary artery (ULMCA). Methods and results: One hundred and forty …

Long‐term outcome in patients treated with first‐versus second‐generation drug‐eluting stents for the treatment of unprotected left main coronary artery stenosis

LJC van Zandvoort, RJ van Bommel… - Catheterization and …, 2020 - Wiley Online Library
Objective and background The study aim is to provide long‐term clinical outcome after
percutaneous coronary intervention (PCI) for unprotected left main coronary arteries …

Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary …

T Naganuma, A Chieffo, E Meliga, D Capodanno… - JACC: Cardiovascular …, 2013 - jacc.org
Objectives: The aim of this study was to compare, in a large all-comer registry, the long-term
clinical outcomes after percutaneous coronary intervention (PCI) with drug-eluting stents …

New-generation drug-eluting stent experience in the percutaneous treatment of unprotected left main coronary artery disease: the NEST registry.

C Bernelli, A Chieffo, GL Buchanan… - The Journal of …, 2013 - europepmc.org
Objectives To explore the 2-year clinical outcomes in patients with unprotected left main
coronary artery (ULMCA) disease treated with overall new drug-eluting stent (DES) options …

Comparison of Drug-Eluting Stent With Bare Metal Stent for Distal De Novo Unprotected Left Main Coronary Artery Stenosis–A Propensity Score-Matched Cohort …

SK Hsueh, CJ Wu, HY Fang, YK Hsieh, CY Fang… - Circulation …, 2011 - jstage.jst.go.jp
Background: Percutaneous coronary intervention (PCI) with stent implantation is now
considered a safe and feasible treatment for stenosis of the unprotected left main coronary …

Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: the sirolimus vs paclitaxel …

E Meliga, HM Garcia-Garcia, M Valgimigli… - International journal of …, 2009 - Elsevier
AIM: To compare the long-term relative efficacy and safety of SES and PES in patients
undergoing percutaneous coronary intervention (PCI) for unprotected left main coronary …

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main …

T Naganuma, A Chieffo, E Meliga, D Capodanno… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: The aim of this study was to report the long-term clinical outcomes after
percutaneous coronary intervention (PCI) with drug-eluting stents (DES) versus coronary …

Impact of previous drug-eluting stent restenosis in non-left main coronary artery lesions on long-term outcomes after left main coronary artery stenting: an observation …

H Higami, M Toyofuku, T Morimoto, M Ohya… - Cardiovascular …, 2018 - Springer
We hypothesized that patients who had previous target-lesion revascularization (TLR) for
DES restenosis in non-left main coronary artery (LMCA) lesions might have a higher risk for …

Provisional vs. two-stent technique for unprotected left main coronary artery disease after ten years follow up: a propensity matched analysis

F D'Ascenzo, M Iannaccone, F Giordana… - International Journal of …, 2016 - Elsevier
Aims There is uncertainty on which stenting approach confers the best long-term outlook for
unprotected left main (ULM) bifurcation disease. Methods and results This is a non …